Health - Google News: Thyroid Cancer Drug Gets FDA OK - MedPage Today

Health - Google News Google News

Thyroid Cancer Drug Gets FDA OK - MedPage Today Nov 29th 2012, 22:26 MedPage Today Thyroid Cancer Drug Gets FDA OK MedPage Today SILVER SPRING, Md. -- The FDA has approved cabozantinib (Cometriq) for metastatic medullary thyroid cancer, even though the drug did not prolong overall survival in clinical trials. The agency was evidently satisfied enough with trial results showing a ... FDA approves drug for rare thyroid cancerBusinessweek Cometriq Approved for Rare Thyroid CancerU.S. News & World Report Exelixis's Thyroid Cancer Treatment Gains U.S. ApprovalBloomberg FierceBiotech -Reuters -TheStreet.com all 32 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: